University of Virginia Health: Research Breakthroughs Lead to Potential New Parkinson's Drug
October 28, 2025
October 28, 2025
CHARLOTTESVILLE, Virginia, Oct. 28 -- University of Virginia Health issued the following news release:
* * *
Research Breakthroughs Lead to Potential New Parkinson's Drug
AbbVie Pharmaceuticals has submitted a New Drug Application (NDA) to the federal Food and Drug Administration for the first novel drug treatment for Parkinson's disease in more than half a century. The drug tavapadon selectively activates a brain target called the D1 dopamine rec . . .
* * *
Research Breakthroughs Lead to Potential New Parkinson's Drug
AbbVie Pharmaceuticals has submitted a New Drug Application (NDA) to the federal Food and Drug Administration for the first novel drug treatment for Parkinson's disease in more than half a century. The drug tavapadon selectively activates a brain target called the D1 dopamine rec . . .